Verition Fund Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.8K | Sell |
14,050
-16,460
| -54% | -$16.2K | ﹤0.01% | 2833 |
|
2025
Q1 | $43.9K | Buy |
30,510
+16,460
| +117% | +$23.7K | ﹤0.01% | 2535 |
|
2024
Q4 | $30.9K | Hold |
14,050
| – | – | ﹤0.01% | 2485 |
|
2024
Q3 | $23.2K | Hold |
14,050
| – | – | ﹤0.01% | 2362 |
|
2024
Q2 | $31.2K | Hold |
14,050
| – | – | ﹤0.01% | 2185 |
|
2024
Q1 | $37.7K | Hold |
14,050
| – | – | ﹤0.01% | 2040 |
|
2023
Q4 | $42K | Sell |
14,050
-75,000
| -84% | -$224K | ﹤0.01% | 1741 |
|
2023
Q3 | $87.3K | Sell |
89,050
-61,645
| -41% | -$60.4K | ﹤0.01% | 1779 |
|
2023
Q2 | $209K | Buy |
150,695
+96,289
| +177% | +$134K | ﹤0.01% | 1560 |
|
2023
Q1 | $86.5K | Buy |
54,406
+39,156
| +257% | +$62.3K | ﹤0.01% | 1752 |
|
2022
Q4 | $95K | Sell |
15,250
-18,670
| -55% | -$116K | ﹤0.01% | 1447 |
|
2022
Q3 | $227K | Buy |
33,920
+17,120
| +102% | +$115K | ﹤0.01% | 1851 |
|
2022
Q2 | $107K | Buy |
+16,800
| New | +$107K | ﹤0.01% | 1979 |
|
2019
Q3 | – | Sell |
-4,833
| Closed | -$225K | – | 1010 |
|
2019
Q2 | $225K | Buy |
+4,833
| New | +$225K | 0.01% | 847 |
|